Cucurbitacin-B inhibits cancer cell migration by targeting mortalin and HDM2: computational and in vitro experimental evidence

References

• Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., & Sacerdoti, F. D. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters [Paper presentation]. In Proceedings of the 2006 ACM/IEEE Conference on Supercomputing. https://doi.org/10.1145/1188455.1188544
   Google Scholar
• Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424. https://doi.org/10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Capuozzo, M., Santorsola, M., Bocchetti, M., Perri, F., Cascella, M., Granata, V., Celotto, V., Gualillo, O., Cossu, A. M., Nasti, G., Caraglia, M., & Ottaiano, A. (2022). p53: From fundamental biology to clinical applications in cancer. Biology (Basel), 11(9), 1325. https://doi.org/10.3390/biology11091325
   PubMedGoogle Scholar
• Cheung, C. T., Hasan, M. K., Widodo, N., Kaul, S. C., & Wadhwa, R. (2009). CARF: An emerging regulator of p53 tumor suppressor and senescence pathway. Mechanisms of Ageing and Development, 130(1-2), 18–23. https://doi.org/10.1016/j.mad.2008.05.002
   PubMed Web of Science ®Google Scholar
• Dhaliwal, D., & Shepherd, T. G. (2022). Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: A review. Clinical & Experimental Metastasis, 39(2), 291–301. https://doi.org/10.1007/s10585-021-10136-5
   PubMed Web of Science ®Google Scholar
• Fedele, M., Sgarra, R., Battista, S., Cerchia, L., & Manfioletti, G. (2022). The Epithelial-Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression. International Journal of Molecular Sciences, 23(2), 800.
   Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein − ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Garg, S., Huifu, H., Kumari, A., Sundar, D., Kaul, S. C., & Wadhwa, R. (2020). Induction of senescence in cancer cells by a novel combination of Cucurbitacin B and Withanone: Molecular mechanism and therapeutic potential. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 75(6), 1031–1041. https://doi.org/10.1093/gerona/glz077
   PubMed Web of Science ®Google Scholar
• Garg, S., Kaul, S. C., & Wadhwa, R. (2018). Cucurbitacin B and cancer intervention: Chemistry, biology and mechanisms (Review). International Journal of Oncology, 52(1), 19–37. https://doi.org/10.3892/ijo.2017.4203
   PubMed Web of Science ®Google Scholar
• Grover, A., Priyandoko, D., Gao, R., Shandilya, A., Widodo, N., Bisaria, V. S., Kaul, S. C., Wadhwa, R., & Sundar, D. (2012). Withanone binds to mortalin and abrogates mortalin-p53 complex: Computational and experimental evidence. The International Journal of Biochemistry & Cell Biology, 44(3), 496–504. https://doi.org/10.1016/j.biocel.2011.11.021
   PubMed Web of Science ®Google Scholar
• Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. https://doi.org/10.1021/acs.jctc.5b00864
   PubMed Web of Science ®Google Scholar
• Huang, C. (2010). Roles of E3 ubiquitin ligases in cell adhesion and migration. Cell Adhesion & Migration, 4(1), 10–18. https://doi.org/10.4161/cam.4.1.9834
   PubMed Web of Science ®Google Scholar
• Kalra, R. S., Chaudhary, A., Yoon, A. R., Bhargava, P., Omar, A., Garg, S., Yun, C. O., Kaul, S. C., & Wadhwa, R. (2018). CARF enrichment promotes epithelial-mesenchymal transition via Wnt/beta-catenin signaling: Its clinical relevance and potential as a therapeutic target. Oncogenesis, 7(5), 39. https://doi.org/10.1038/s41389-018-0048-4
   PubMedGoogle Scholar
• Kamrul, H. M., Wadhwa, R., & Kaul, S. C. (2007). CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway. Annals of the New York Academy of Sciences, 1100, 312–315. https://doi.org/10.1196/annals.1395.033
   PubMed Web of Science ®Google Scholar
• Kaul, Z., Cheung, C. T. Y., Bhargava, P., Sari, A. N., Yu, Y., Huifu, H., Bid, H., Henson, J. D., Groden, J., Reddel, R. R., Kaul, S. C., & Wadhwa, R. (2021). Functional characterization of miR-708 microRNA in telomerase positive and negative human cancer cells. Scientific Reports, 11(1), 17052. https://doi.org/10.1038/s41598-021-96096-y
   PubMed Web of Science ®Google Scholar
• Lu, W. J., Lee, N. P., Kaul, S. C., Lan, F., Poon, R. T., Wadhwa, R., & Luk, J. M. (2011a). Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy. Cell Death and Differentiation, 18(6), 1046–1056. https://doi.org/10.1038/cdd.2010.177
   PubMed Web of Science ®Google Scholar
• Lu, W. J., Lee, N. P., Kaul, S. C., Lan, F., Poon, R. T., Wadhwa, R., & Luk, J. M. (2011b). Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. International Journal of Cancer, 129(8), 1806–1814. https://doi.org/10.1002/ijc.25857
   PubMed Web of Science ®Google Scholar
• Luo, W. W., Zhao, W. W., Lu, J. J., Wang, Y. T., & Chen, X. P. (2018). Cucurbitacin B suppresses metastasis mediated by reactive oxygen species (ROS) via focal adhesion kinase (FAK) in breast cancer MDA-MB-231 cells. Chinese Journal of Natural Medicines, 16(1), 10–19. https://doi.org/10.1016/S1875-5364(18)30025-6
   PubMed Web of Science ®Google Scholar
• Madhavi Sastry, G., Adzhigirey, M., Day, T., Annabhimoju, R., & Sherman, W. (2013). Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. Journal of Computer-Aided Molecular Design, 27(3), 221–234. https://doi.org/10.1007/s10822-013-9644-8
   PubMed Web of Science ®Google Scholar
• Na, Y., Kaul, S. C., Ryu, J., Lee, J. S., Ahn, H. M., Kaul, Z., Kalra, R. S., Li, L., Widodo, N., Yun, C. O., & Wadhwa, R. (2016). Stress chaperone mortalin contributes to epithelial-mesenchymal transition and cancer metastasis. Cancer Research, 76(9), 2754–2765.
   Google Scholar
• Omar, A., Kalra, R. S., Putri, J., Elwakeel, A., Kaul, S. C., & Wadhwa, R. (2020). Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells. Scientific Reports, 10(1), 6323. https://doi.org/10.1038/s41598-020-62953-5
   PubMed Web of Science ®Google Scholar
• Patil, M. R., & Bihari, A. (2022). A comprehensive study of p53 protein. Journal of Cellular Biochemistry, 123(12), 1891–1937. https://doi.org/10.1002/jcb.30331
   PubMed Web of Science ®Google Scholar
• Piao, X. M., Gao, F., Zhu, J. X., Wang, L. J., Zhao, X., Li, X., Sheng, M. M., & Zhang, Y. (2018). Cucurbitacin B inhibits tumor angiogenesis by triggering the mitochondrial signaling pathway in endothelial cells. International Journal of Molecular Medicine, 42(2), 1018–1025. https://doi.org/10.3892/ijmm.2018.3647
   PubMed Web of Science ®Google Scholar
• Rinaldo, C., Prodosmo, A., Mancini, F., Iacovelli, S., Sacchi, A., Moretti, F., & Soddu, S. (2007). MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Molecular Cell, 25(5), 739–750. https://doi.org/10.1016/j.molcel.2007.02.008
   PubMed Web of Science ®Google Scholar
• Rubtsova, S. N., Zhitnyak, I. Y., & Gloushankova, N. A. (2022). Dual role of E-cadherin in cancer cells. Tissue Barriers, 10(4), 2005420. https://doi.org/10.1080/21688370.2021.2005420
   PubMed Web of Science ®Google Scholar
• Ryu, J., Kaul, Z., Yoon, A. R., Liu, Y., Yaguchi, T., Na, Y., Ahn, H. M., Gao, R., Choi, I. K., Yun, C. O., Kaul, S. C., & Wadhwa, R. (2014). Identification and functional characterization of nuclear mortalin in human carcinogenesis. The Journal of Biological Chemistry, 289(36), 24832–24844. https://doi.org/10.1074/jbc.M114.565929
   PubMed Web of Science ®Google Scholar
• Schrödinger, G. (2020). Schrödinger Release 2020-1: Maestro 019-3SR, LigPrep, Protein Preparation Wizard, Prime, Desmond Molecular Dynamics System. Maestro-Desmond Interoperability Tools. Schrödinger, LLC.
   Google Scholar
• Shukla, S., Sinha, S., Khan, S., Kumar, S., Singh, K., Mitra, K., Maurya, R., & Meeran, S. M. (2016). Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/beta-catenin signaling axis. Scientific Reports, 6, 21860. https://doi.org/10.1038/srep21860
   PubMed Web of Science ®Google Scholar
• Smeenk, L., van Heeringen, S. J., Koeppel, M., Gilbert, B., Janssen-Megens, E., Stunnenberg, H. G., & Lohrum, M. (2011). Role of p53 serine 46 in p53 target gene regulation. PLoS One, 6(3), e17574. https://doi.org/10.1371/journal.pone.0017574
   PubMed Web of Science ®Google Scholar
• Sung, Y. J., Kao, T. Y., Kuo, C. L., Fan, C. C., Cheng, A. N., Fang, W. C., Chou, H. Y., Lo, Y. K., Chen, C. H., Jiang, S. S., Chang, I. S., Hsu, C. H., Lee, J. C., & Lee, A. Y. (2018). Mitochondrial Lon sequesters and stabilizes p53 in the matrix to restrain apoptosis under oxidative stress via its chaperone activity. Cell Death & Disease, 9(6), 697. https://doi.org/10.1038/s41419-018-0730-7
   PubMedGoogle Scholar
• Tang, L., Fu, L., Zhu, Z., Yang, Y., Sun, B., Shan, W., & Zhang, Z. (2018). Modified mixed nanomicelles with collagen peptides enhanced oral absorption of Cucurbitacin B: Preparation and evaluation. Drug Delivery, 25(1), 862–871. https://doi.org/10.1080/10717544.2018.1425773
   PubMed Web of Science ®Google Scholar
• Thoennissen, N. H., Iwanski, G. B., Doan, N. B., Okamoto, R., Lin, P., Abbassi, S., Song, J. H., Yin, D., Toh, M., Xie, W. D., Said, J. W., & Koeffler, H. P. (2009). Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Cancer Research, 69(14), 5876–5884. https://doi.org/10.1158/0008-5472.CAN-09-0536
   PubMed Web of Science ®Google Scholar
• Thomas, A. F., Kelly, G. L., & Strasser, A. (2022). Of the many cellular responses activated by TP53, which ones are critical for tumour suppression? Cell Death and Differentiation, 29(5), 961–971. https://doi.org/10.1038/s41418-022-00996-z
   PubMed Web of Science ®Google Scholar
• Wadhwa, R., Taira, K., & Kaul, S. C. (2002). Mortalin: A potential candidate for biotechnology and biomedicine. Histology and Histopathology, 17(4), 1173–1177.
   PubMed Web of Science ®Google Scholar
• Wang, K., Ye, H., Zhang, X., Wang, X., Yang, B., Luo, C., Zhao, Z., Zhao, J., Lu, Q., Zhang, H., Kan, Q., Wang, Y., He, Z., & Sun, J. (2020). An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition. Biomaterials, 257, 120224. https://doi.org/10.1016/j.biomaterials.2020.120224
   PubMed Web of Science ®Google Scholar
• Yoon, A. R., Wadhwa, R., Kaul, S. C., & Yun, C. O. (2022). Why is mortalin a potential therapeutic target for cancer? Frontiers in Cell and Developmental Biology, 10, 914540. https://doi.org/10.3389/fcell.2022.914540
   PubMed Web of Science ®Google Scholar
• Zeng, Y., Wang, J., Huang, Q., Ren, Y., Li, T., Zhang, X., Yao, R., & Sun, J. (2021). Cucurbitacin IIa: A review of phytochemistry and pharmacology. Phytotherapy Research : PTR, 35(8), 4155–4170. https://doi.org/10.1002/ptr.7077
   PubMed Web of Science ®Google Scholar
• Zhang, H., Zhao, B., Wei, H., Zeng, H., Sheng, D., & Zhang, Y. (2022). Cucurbitacin B controls M2 macrophage polarization to suppresses metastasis via targeting JAK-2/STAT3 signalling pathway in colorectal cancer. Journal of Ethnopharmacology, 287, 114915. https://doi.org/10.1016/j.jep.2021.114915
   PubMed Web of Science ®Google Scholar
• Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H. (2022). Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target. Molecular Cancer, 21(1), 144. https://doi.org/10.1186/s12943-022-01616-7
   PubMed Web of Science ®Google Scholar
• Zheng, Q., Liu, Y., Liu, W., Ma, F., Zhou, Y., Chen, M., Chang, J., Wang, Y., Yang, G., & He, G. (2014). Cucurbitacin B inhibits growth and induces apoptosis through the JAK2/STAT3 and MAPK pathways in SHSY5Y human neuroblastoma cells. Molecular Medicine Reports, 10(1), 89–94. https://doi.org/10.3892/mmr.2014.2175
   PubMed Web of Science ®Google Scholar